Anal Fistula, Anoperineal Fistula, Crohn Disease, Fistula
Conditions
Keywords
Crohn Disease, Anoperineal fistula, Anal fistula, Proctology, Drainage, Colorectal Surgery, Fistulotomy, Plug, Advancement flap, Glue, Anti Tumor Necrosis Factor-alpha, Adalimumab
Brief summary
The purpose of this study is to demonstrate, in patients treated with adalimumab, the efficacy of proctological surgery in anoperineal fistula healing after the removal of seton drain.
Interventions
PROCEDUREAll types of surgery procedures
All types of surgery procedures used for anoperineal fistula repair. Surgery procedures include fistulotomy, biological glue, rectal advancement flap and plug.
PROCEDURESimple seton drain removal
Patients are simply followed after seton drain removal.
Sponsors
French Society of Coloproctology
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* male or female 18 years or older, * women of childbearing age who use an effective contraception method or women incapable of becoming pregnant \[(i.e. postmenopausal women for 1 year or surgically sterile (hysterectomy and/or bilateral oophorectomy)\], * Patient with fistulizing anoperineal Crohn's disease. Anoperineal fistulas can be associated with ileal, colic or rectal lesions, * Patient with at least 1 anoperineal fistula drained with a seton for more than 1 month, * Patient treated with adalimumab for more than 1 month, * Patient who agrees to undergo surgery for its drained fistula(s), * Patient with immunosuppressive therapy (azathioprine, 6-mercaptopurine ou methotrexate) stable for at least 3 months or patients without immunosuppressive therapy, * Patient who gave signed written informed consent after having received verbal explanation and written information related to the trial.
Exclusion criteria
* Pregnant or breastfeeding women, * Patient having a perineal abscess, * Patient with a high anovaginal fistula that cannot be treated, according to the investigator ,with fistulotomy, gluing, biodegradable plug or advancement flap, * Patient treated with a daily dose of corticosteroids of more than 20 mg (a dose of more than 20 mg daily will be authorized during the study), * Contraindication to proctological surgery on the drained fistula(s), * Patient presenting with somatic or psychic signs or symptoms that are not compatible with his/her participation in the trial according to the investigator, * Patient who participate in another clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of patients having a clinical healing of their anoperineal fistulas in Crohn disease | 12 months after seton drain removal |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Crohn disease activity assessed by Crohn's Disease Activity Index (CDAI) and Perianal Disease Activity Index (PDAI) | 3, 6, 12 and 24 months after seton drain removal | — |
| Change in anal continence assessed by Wexner and Vaizey scores | 12 and 24 months after seton drain removal | — |
| Crohn's Disease Endoscopic Index of Severity (CDEIS) | 12 months after seton drain removal | — |
| Proportion of patients having more than half of their fistulas healed | 3, 6, 12 and 24 months after seton drain removal | — |
| Change in fistula activity assessed by magnetic resonance imaging (MRI) | 6, 12 and 24 months after seton drain removal | Change in fistula activity assessed by MRI (Van Assche score and absence of contrast enhancement after injection of gadolinium with regards to fistulous tract |
| Change in discomfort and impact assessed by the patient using a visual analog scale (VAS) | 3, 6, 12 and 24 months after seton drain removal | — |
| Change in patients' quality of life, assessed by the Inflammatory Bowel Disease Questionnaire (IBDQ) | 12 and 24 months after seton drain removal | — |
Countries
France
Contacts
Primary ContactLaurent Abramowitz, MD
Outcome results
None listed